Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Share-based Compensation (2021 - 2025)

Tenon Medical has reported Share-based Compensation over the past 5 years, most recently at $344000.0 for Q4 2025.

  • Quarterly results put Share-based Compensation at $344000.0 for Q4 2025, down 61.04% from a year ago — trailing twelve months through Dec 2025 was $1.7 million (down 56.02% YoY), and the annual figure for FY2025 was $1.7 million, down 56.02%.
  • Share-based Compensation for Q4 2025 was $344000.0 at Tenon Medical, up from $58000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for TNON hit a ceiling of $4.1 million in Q4 2023 and a floor of -$172000.0 in Q3 2021.
  • Median Share-based Compensation over the past 5 years was $712000.0 (2022), compared with a mean of $793948.0.
  • Biggest five-year swings in Share-based Compensation: plummeted 99.9% in 2023 and later surged 98002.47% in 2024.
  • Tenon Medical's Share-based Compensation stood at $1.0 million in 2021, then soared by 113.33% to $2.2 million in 2022, then soared by 90.34% to $4.1 million in 2023, then plummeted by 78.68% to $883000.0 in 2024, then plummeted by 61.04% to $344000.0 in 2025.
  • The last three reported values for Share-based Compensation were $344000.0 (Q4 2025), $58000.0 (Q3 2025), and $417000.0 (Q2 2025) per Business Quant data.